Database: Complete database on drug expenditure (France): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
'''Data level:''' [[availableDataLevel::regional level]]. | '''Data level:''' [[availableDataLevel::regional level]]. | ||
'''Number of Records:''' | '''Number of Records:''' [[numberRecords::unknown]]. | ||
'''Date range:''' [[dataStart::2014]] | '''Date range:''' [[dataStart::2014]] [[dataEnd::onwards]]. | ||
'''Cancer areas of interest:'''[[hasCancerType::C00-D48: All neoplasms]] [https://www.assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-base-complete-depenses-medicaments]. | '''Cancer areas of interest:'''[[hasCancerType::C00-D48: All neoplasms]] [https://www.assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-base-complete-depenses-medicaments]. | ||
Revision as of 18:42, 27 April 2024
Go back to France page
Primary purpose: To provide an annual database of medication reimbursements dispensed in community pharmacies across France.
Sponsor, manager or home institution: Caisse Nationale de l'Assurance Maladie (CNAM) [1].
Type of information: Data Dictionary: Open Medic: complete database on drug expenditure [2].
Source of information: Système National des Données de Santé (SNDS) [3].
Data level: regional level.
Number of Records: unknown.
Date range: 2014 onwards.
Cancer areas of interest:C00-D48: All neoplasms [4].
Data access: publicly available [5].
Contact information: Information [6].
